Expanded Access Program for Maraviroc At Multiple Centers
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
To provide access to maraviroc to patients who have limited or no therapeutic treatment
options and to collect more safety data in a broader patient population.